Philips unveils next-gen CT system ‘Rembra’
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
Merck emphasized the broader significance of the findings
This study evaluated a difficult-to-treat Crohn's disease patient population
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
During live demonstrations, industry leaders highlighted SEOPRO’s ability to spot portfolio risk, execution bottlenecks, and decision delays early—before they escalate into costly program disruptions
KEYTRUDA had previously met its primary endpoint of progression-free survival in all patients
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The results, published in The Lancet, showed orforglipron delivered significantly greater reductions in both A1C and body weight across primary and key secondary endpoints
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
Subscribe To Our Newsletter & Stay Updated